Berberine (BBR), an isoquinoline derivative alkaloid isolated from Chinese herbs, has a long history of uses for the treatment of multiple diseases, including cancers. However, the precise mechanisms of actions of BBR in human lung cancer cells remain unclear. In this study, we investigated the molecular mechanisms by which BBR inhibits cell growth in human non-small-cell lung cancer (NSCLC) cells. Treatment with BBR promoted cell morphology change, inhibited cell migration, proliferation and colony formation, and induced cell apoptosis. Further molecular mechanism study showed that BBR simultaneously targeted multiple cell signaling pathways to inhibit NSCLC cell growth. Treatment with BBR inhibited AP-2α and AP-2β expression and abrogated their binding on hTERT promoters, thereby inhibiting hTERT expression. Knockdown of AP-2α and AP-2β by siRNA considerably augmented the BBR-mediated inhibition of cell growth. BBR also suppressed the nuclear translocation of p50/p65 NF-κB proteins and their binding to COX-2 promoter, causing inhibition of COX-2. BBR also downregulated HIF-1α and VEGF expression and inhibited Akt and ERK phosphorylation. Knockdown of HIF-1α by siRNA considerably augmented the BBR-mediated inhibition of cell growth. Moreover, BBR treatment triggered cytochrome-c release from mitochondrial inter-membrane space into cytosol, promoted cleavage of caspase and PARP, and affected expression of BAX and Bcl-2, thereby activating apoptotic pathway. Taken together, these results demonstrated that BBR inhibited NSCLC cell growth by simultaneously targeting AP-2/hTERT, NF-κB/COX-2, HIF-1α/VEGF, PI3K/AKT, Raf/MEK/ERK and cytochrome-c/caspase signaling pathways. Our findings provide new insights into understanding the anticancer mechanisms of BBR in human lung cancer therapy.
References
[1]
Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62: 10-29. doi:10.3322/caac.20138. PubMed: 22237781.
[2]
Schiller JH, Harrington D, Belani CP, Langer C, Sandler A et al. (2002) Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 346: 92-98. doi:10.1056/NEJMoa011954. PubMed: 11784875.
[3]
Klastersky J, Awada A (2012) Milestones in the use of chemotherapy for the management of non-small cell lung cancer (NSCLC). Crit Rev Oncol/Hematol 81: 49-57. PubMed: 21396829.
[4]
Chen S, Flower A, Ritchie A, Liu JP, Molassiotis A et al. (2010) Oral Chinese herbal medicine (CHM) as an adjuvant treatment during chemotherapy for non-small cell lung cancer: A systematic review. Lung Cancer 68: 137-145. doi:10.1016/j.lungcan.2009.11.008. PubMed: 20015572.
[5]
May BH, Lu CJ, Bennett L, Hügel HM, Xue CCL (2012) Evaluating the traditional Chinese literature for herbal formulae and individual herbs used for age-related dementia and memory impairment. Biogerontology 13: 299-312. doi:10.1007/s10522-012-9375-6. PubMed: 22311547.
[6]
Sundin T, Peffley DM, Hentosh P (2013) Disruption of an hTERT-mTOR-RAPTOR protein complex by a phytochemical perillyl alcohol and rapamycin. Mol Cell Biochem 375: 97-104. PubMed: 23283642.
[7]
Ikram M (1975) A review on the chemical and pharmacological aspects of genus Berberis. Planta Med 28: 353-358. doi:10.1055/s-0028-1097869. PubMed: 1208684.
[8]
Jeong HW, Hsu KC, Lee JW, Ham M, Huh JY et al. (2009) Berberine suppresses proinflammatory responses through AMPK activation in macrophages. Am J Physiol Endocrinol Metab 296: E955-E964. doi:10.1152/ajpendo.90599.2008. PubMed: 19208854.
[9]
Zhao HP, Hong Y, Xie JD, Xie XR, Wang J et al. (2007) [Effect of berberine on left ventricular remodeling in renovascular hypertensive rats]. Yao Xue Xue Bao 42: 336-341. PubMed: 17520837.
[10]
Briand F, Thieblemont Q, Muzotte E, Sulpice T (2013) Upregulating Reverse Cholesterol Transport With Cholesteryl Ester Transfer Protein Inhibition Requires Combination With the LDL-Lowering Drug Berberine in Dyslipidemic Hamsters. Arterioscler Thromb Vasc Biol 33: 13–23 +. doi:10.1161/ATVBAHA.112.252932. . PubMed : 23139291.
[11]
Joshi PV, Shirkhedkar AA, Prakash K, Maheshwari VL (2011) Antidiarrheal activity, chemical and toxicity profile of Berberis aristata. Pharm Biol 49: 94-100. doi:10.3109/13880209.2010.500295. PubMed: 20738174.
[12]
Zhang YG, Wang X, Sha SM, Liang SL, Zhao LN et al. (2012) Berberine increases the expression of NHE3 and AQP4 in sennosideA-induced diarrhoea model. Fitoterapia 83: 1014-1022. doi:10.1016/j.fitote.2012.05.015. PubMed: 22668974.
[13]
Fiamegos YC, Kastritis PL, Exarchou V, Han H, Amjj Bonvin et al. (2011) Antimicrobial and Efflux Pump Inhibitory Activity of Caffeoylquinic Acids from Artemisia absinthium against Gram-Positive Pathogenic Bacteria. PLOS ONE 6: e18127. PubMed: 21483731.
[14]
Ge HX, Zhang J, Chen L, Kou JP, Yu BY (2013) Chemical and microbial semi-synthesis of tetrahydroprotoberberines as inhibitors on tissue factor procoagulant activity. Bioorg Med Chem 21: 62-69. doi:10.1016/j.bmc.2012.11.002. PubMed: 23199480.
[15]
Goto H, Kariya R, Shimamoto M, Kudo E, Taura M et al. (2012) Antitumor effect of berberine against primary effusion lymphoma via inhibition of NF-?B pathway. Cancer Sci 103: 775-781. doi:10.1111/j.1349-7006.2012.02212.x. PubMed: 22320346.
[16]
Hamsa TP, Kuttan G (2012) Berberine Inhibits Pulmonary Metastasis through Down-regulation of MMP in Metastatic B16F-10 Melanoma Cells. Phytother Res 26: 568-578. doi:10.1002/ptr.3586. PubMed: 21953764.
[17]
Eom KS, Kim HJ, So HS, Park R, Kim TY (2010) Berberine-Induced Apoptosis in Human Glioblastoma T98G Cells Is Mediated by Endoplasmic Reticulum Stress Accompanying Reactive Oxygen Species and Mitochondrial Dysfunction. Biol Pharm Bull 33: 1644-1649. doi:10.1248/bpb.33.1644. PubMed: 20930370.
[18]
Kim HS, Kim MJ, Kim EJ, Yang Y, Lee MS et al. (2012) Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem Pharmacol 83: 385-394. doi:10.1016/j.bcp.2011.11.008. PubMed: 22120676.
[19]
Park JJ, Seo SM, Kim EJ, Lee YJ, Ko YG et al. (2012) Berberine inhibits human colon cancer cell migration via AMP-activated protein kinase-mediated downregulation of integrin beta 1 signaling. Biochem Biophys Res Commun 426: 461-467. doi:10.1016/j.bbrc.2012.08.091. PubMed: 22943849.
[20]
Patil JB, Kim J, Jayaprakasha GK (2010) Berberine induces apoptosis in breast cancer cells (MCF-7) through mitochondrial-dependent pathway. Eur J Pharmacol 645: 70-78. doi:10.1016/j.ejphar.2010.07.037. PubMed: 20691179.
[21]
Wang J, Liu Q, Yang QF (2012) Radiosensitization effects of berberine on human breast cancer cells. Int J Mol Med 30: 1166-1172. PubMed: 22895634.
[22]
Li J, Cao B, Liu XC, Fu XQ, Xiong ZG et al. (2011) Berberine Suppresses Androgen Receptor Signaling in Prostate Cancer. Mol Cancer Ther 10: 1346-1356. doi:10.1158/1535-7163.MCT-10-0985. PubMed: 21613449.
[23]
Peng PL, Kuo WH, Tseng HC, Chou FP (2008) Synergistic tumor-killing effect of radiation and berberine combined treatment in lung cancer: The contribution of autophagic cell death. Int J Radiat Oncol Biol Phys 70: 529-542. doi:10.1016/j.ijrobp.2007.08.034. PubMed: 18207031.
[24]
Liu YF, Yu HM, Zhang C, Chen YF, Hu LK et al. (2008) Protective effects of berberine on radiation-induced lung injury via intercellular adhesion molecular-1 and transforming growth factor-beta-1 in patients with lung cancer. Eur J Cancer 44: 2425-2432. doi:10.1016/j.ejca.2008.07.040. PubMed: 18789680.
[25]
Peng PL, Hsieh YS, Wang CJ, Hsu JL, Chou FP (2006) Inhibitory effect of berberine on the invasion of human lung cancer cells via decreased productions of urokinase-plasminogen activator and matrix metalloproteinase-2. Toxicology and Applied Pharmacology 214: 8-15.
[26]
Sung JH, Kim JB, Park SH, Park SY, Lee JK et al. (2012) Berberine Decreases Cell Growth but Increases the Side Population Fraction of H460 Lung Cancer Cells. J Korean Soc Appl Biol Chem 55: 491-495. doi:10.1007/s13765-012-2119-0.
[27]
Stewart SA, Hahn WC, O’Connor BF, Banner EN, Lundberg AS et al. (2002) Telomerase contributes to turnorigenesis by a telomere length-independent mechanism. Proc Natl Acad Sci U S A 99: 12606-12611. doi:10.1073/pnas.182407599. PubMed: 12193655.
[28]
Van den Berg RM, Brokx H, Vesin A, Field JK, Brambilla C et al. (2010) Prognostic value of hTERT mRNA expression in surgical samples of lung cancer patients: the European Early Lung Cancer Project. Int J Oncol 37: 455-461. PubMed: 20596673.
[29]
Kyo S, Takakura M, Fujiwara T, Inoue M (2008) Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers. Cancer Sci 99: 1528-1538. doi:10.1111/j.1349-7006.2008.00878.x. PubMed: 18754863.
[30]
Riechmann JL, Meyerowitz EM (1998) The AP2/EREBP family of plant transcription factors. Biol Chem 379: 633-646. PubMed: 9687012.
[31]
Deng WG, Jayachandran G, Wu G, Xu K, Roth JA et al. (2007) Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2 beta in human lung cancer cells. J Biol Chem 282.
[32]
Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9: 669-676. doi:10.1038/nm0603-669. PubMed: 12778165.
[33]
Takenaka K, Yamagishi S, Jinnouchi Y, Nakamura K, Matsui T et al. (2005) Pigment epithelium-derived factor (PEDF)-induced apoptosis and inhibition of vascular endothelial growth factor (VEGF) expression in MG63 human osteosarcoma cells. Life Sci 77: 3231-3241. doi:10.1016/j.lfs.2005.05.048. PubMed: 15985268.
[34]
Shi DB, Guo W, Chen WB, Fu LY, Wang JS et al. (2012) Nicotine Promotes Proliferation of Human Nasopharyngeal Carcinoma Cells by Regulating alpha 7AChR, ERK, HIF-1alpha and VEGF/PEDF Signaling. PLOS ONE 7.
[35]
Hagen T, Taylor CT, Lam F, Moncada S (2003) Redistribution of intracellular oxygen in hypoxia by nitric oxide: effect on HIF1alpha. Science 302: 1975-1978. doi:10.1126/science.1088805. PubMed: 14671307.
[36]
Du R, Lu KV, Petritsch C, Liu P, Ganss R et al. (2008) HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion. Cancer Cell 13: 206-220. doi:10.1016/j.ccr.2008.01.034. PubMed: 18328425.
[37]
Edwards J, Mukherjee R, Munro AF, Wells AC, Almushatat A et al. (2004) HER2 and COX2 expression in human prostate cancer. Eur J Cancer 40: 50-55. doi:10.1016/j.ejca.2003.08.010. PubMed: 14687789.
[38]
Hollingshead HE, Borland MG, Billin AN, Willson TM, Gonzalez FJ et al. (2008) Ligand activation of peroxisome proliferator-activated receptor-beta/delta (PPAR beta/delta) and inhibition of cyclooxygenase 2 (COX2) attenuate colon carcinogenesis through independent signaling mechanisms. Carcinogenesis 29: 169-176. PubMed: 17893232.
[39]
Suh Y, Afaq F, Johnson JJ, Mukhtar H (2009) A plant flavonoid fisetin induces apoptosis in colon cancer cells by inhibition of COX2 and Wnt/EGFR/NF-kappa B-signaling pathways. Carcinogenesis 30: 300-307. PubMed: 19037088.
[40]
Abdullah M, Sudoyo A, Hanjari DR, Hernowo B, Rani AA (2010) NF-kappaB and COX2 Expression in Colorectal Cancer among Native Indonesians: The Role of Inflammation in Colorectal Carcinogenesis. Am J Gastroenterol 105: S551-S551. doi:10.1038/ajg.2009.625.
[41]
Lim JH, Lee ES, You HJ, Lee JW, Park JW et al. (2004) Ras-dependent induction of HIF-1alpha785 via the Raf/MEK/ERK pathway: a novel mechanism of Ras-mediated tumor promotion. Oncogene 23: 9427-9431. doi:10.1038/sj.onc.1208003. PubMed: 15543236.
[42]
Riedl SJ, Shi YG (2004) Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol 5: 897-907. doi:10.1038/nrm1496. PubMed: 15520809.
[43]
Katiyar SK, Meeran SM, Katiyar N, Akhtar S (2009) p53 Cooperates Berberine-Induced Growth Inhibition and Apoptosis of Non-Small Cell Human Lung Cancer Cells In Vitro and Tumor Xenograft Growth In Vivo. Mol Carcinog 48: 24-37. doi:10.1002/mc.20453. PubMed: 18459128.
[44]
Deng WG, Jayachandran G, Wu G, Xu K, Roth JA et al. (2007) Tumor-specific activation of human telomerase reverses transcriptase promoter activity by activating enhancer-binding protein-2beta in human lung cancer cells. J Biol Chem 282: 26460-26470. doi:10.1074/jbc.M610579200. PubMed: 17630431.
[45]
de Wilde J, Kooter JM, Overmeer RM, Claassen-Kramer D, Meijer CJLM et al. (2010) hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis. BMC Cancer 10: 271-. PubMed: 20534141.
[46]
Shi D, Guo W, Chen W, Fu L, Wang J et al. (2012) Nicotine promotes proliferation of human nasopharyngeal carcinoma cells by regulating alpha7AChR, ERK, HIF-1alpha and VEGF/PEDF signaling. PLOS ONE 7: e43898. doi:10.1371/journal.pone.0043898. PubMed: 22952803.
[47]
Giatromanolaki A, Koukourakis MI, Sivridis E, Turley H, Talks K et al. (2001) Relation of hypoxia inducible factor 1 alpha and 2 alpha in operable non-small cell lung cancer to angiogenic/molecular profile of tumours and survival. Br J Cancer 85: 881-890. doi:10.1054/bjoc.2001.2018. PubMed: 11556841.
[48]
Rodrigues S, Bruyneel E, Rodrigue CM, Shahin E, Gespach C (2004) [Cyclooxygenase 2 and carcinogenesis]. Bull Cancer 91 Suppl 2: S61-S76. PubMed: 1589962915239333.
[49]
Gollob JA, Wilhelm S, Carter C, Kelley SL (2006) Role of Raf kinase in cancer: therapeutic potential of targeting the Raf/MEK/ERK signal transduction pathway. Semin Oncol 33: 392-406. doi:10.1053/j.seminoncol.2006.04.002. PubMed: 16890795.
[50]
Engelman JA (2009) Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 9: 550-562. doi:10.1038/nrc2664. PubMed: 19629070.
